Whitepaper: Supporting Consumer Access to Specialty Medications through Value-Based Insurance Design
National Pharmaceutical Council & University of Michigan - June 9, 2014
Value-based insurance design (V-BID) is a key tactic payers and purchasers can use to promote access to high-value specialty medications.
ASHP President Jolowsky: Pharmacists Are the Constant in Patient Care
American Society of Health-System Pharmacists - June 4, 2014
Incoming ASHP President Christene M. Jolowsky mixed the wisdom of a favorite author from childhood with her knowledge of mathematics to present her philosophy on pharmacy practice.
Makers of OTC Medicines Applaud Gov. Jindal for Signing HB 514
Consumer Healthcare Products Association - May 28, 2014
Louisiana to be sixth state to pass legislation limiting the sale of over-the-counter cough medicines containing dextromethorphan to minors.
Momenta Pharmaceuticals Receives Orphan Drug Designation for Necuparanib (Formerly M402) in Pancreatic Cancer
Globe Newswire - June 5, 2014
Momenta Pharmaceuticals, Inc. announces that its novel oncology candidate, necuparanib (formerly M402), has received Orphan Drug Designation from the U.S. Food and Drug Administration (FDA) for the treatment of pancreatic cancer.
Chicago Accuses Johnson & Johnson and Others of Causing America’s Painkiller Addiction
Vice News - June 5, 2014
The city of Chicago has filed a scathing 126-page lawsuit against five major pharmaceutical companies that it says are directly responsible for the dramatic rise in America’s addiction to opiate drugs. The suit alleges ten counts of fraud, conspiracy, unjust enrichment, insurance fraud, misrepresentation in advertising, and other violations of Chicago municipal code.
PBM expands access to specialty meds at retail pharmacies
Employee Benefit News - June 3, 2014
With specialty drugs expected to reach as much as half of total drug expenditures within the next few years, pharmacy benefit manager CVS Caremark has launched a new program designed to make the process of filling specialty medication prescriptions easier for plan members.
A Single Drug: 8% Higher Premiums for Seniors on Medicare
AHIP Coverage - June 6, 2014
We’ve discussed the astronomically priced hepatitis C drug, Sovaldi, the concern that this is the new normal, and the outrage its pricing has sparked. Now get ready for some outraged seniors.
FDA requiring lower starting dose for sleep drug Lunesta
U.S. Food and Drug Administration - May 15, 2014
Risk of impairment the morning after use of sleep aid drugs
1 in 10 Heart Attack Patients May Have Undiagnosed Diabetes
HealthDay News - June 3, 2014
As many as one in 10 Americans who has a heart attack may also have undiagnosed diabetes, a new study finds.
CDC: Measles cases in USA hit 20-year high
USA TODAY - May 29, 2014
The USA has the most measles cases in 20 years and the most since homegrown outbreaks were eliminated in 2000, the federal Centers for Disease Control and Prevention announced Thursday.
Study finds high risk of recurrence of two life-threatening adverse drug reactions that affect the skin - SJS and TEN
Medical News Today - June 3, 2014
Individuals who are hospitalized for the skin conditions of Stevens-Johnson syndrome and toxic epidermal necrolysis appear to have a high risk of recurrence, according to a study in JAMA.
Contact,
Kristin LaVitola
Marketing Director, PSG
Pharmaceutical Strategies Group (PSG)
Office: 972-244-8388
Email: KLavitola@PSGConsults.com
PSGNewsletter@PSGConsults.com
www.PSGConsults.com
 |
 |
 |